ResearcherChristian-Albrechts-Universität zu KielNo recent work listed
Karen Legler
Matched on OpenAlex author ID A5082090217. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2015: 1 paper · 2016: none · 2017: 2 papers · 2018: 1 paper
Papers 4
- The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells. Co-author DOI 10.1038/s41419-018-0478-0↗
- Role of CCL20 mediated immune cell recruitment in NF-κB mediated TRAIL resistance of pancreatic cancer. Co-author DOI 10.1016/j.bbamcr.2017.02.005↗
- Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.11299↗
- Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer. Co-author DOI 10.1002/ijc.29445↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Holger Kalthoff · 3 shared papers, 2015–2018 · strength 0.17
- Paper The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells. DOI 10.1038/s41419-018-0478-0↗
- Paper Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma. DOI 10.18632/oncotarget.11299↗
- Paper Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models… DOI 10.1002/ijc.29445↗
- Anna Trauzold · 2 shared papers, 2017–2018 · strength 0.13
- Christoph Röcken · 2 shared papers, 2015–2018 · strength 0.11
- Johannes Lemke · 1 shared paper, 2018 · strength 0.07
- Roberta Peruzzo · 1 shared paper, 2017 · strength 0.06
- Luigi Leanza · 1 shared paper, 2017 · strength 0.06
- Lucia Biasutto · 1 shared paper, 2017 · strength 0.06
- Angela Zaccagnino · 1 shared paper, 2017 · strength 0.06
- Ildikò Szabó · 1 shared paper, 2017 · strength 0.06
- H. Schäfer · 1 shared paper, 2017 · strength 0.06
- Alexander Arlt · 1 shared paper, 2017 · strength 0.06
- Bence Sipos · 1 shared paper, 2017 · strength 0.06
- Zonera Hassan · 1 shared paper, 2017 · strength 0.06
- Claudia Geismann · 1 shared paper, 2017 · strength 0.06
- Günter Schneider · 1 shared paper, 2017 · strength 0.06
- Reinhild Holmer · 1 shared paper, 2015 · strength 0.04
- Freya A. Goumas · 1 shared paper, 2015 · strength 0.04
- Ulf Martin Geisen · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.